AEGLE THERAPEUTICS

In News

Aegle Therapeutics Corp. Announces Positive Data for the First Patient in a Phase 1/2a Clinical Trial Dosed With AGLE-102™, a Novel Extracellular Vesicle Therapy - PR Newswire

PR Newswire - Jan 08, 2024

Clinical trials underway for stem cell-derived ointment for blistering skin disorders - Refresh Miami

Refresh Miami - May 16, 2025

Aegle Therapeutics Prepares Phase 1/2a Trial of BM-MSC Derived Extracellular Vesicles - bioinformant.com

bioinformant.com - Jul 20, 2018

Welcome to the 7th Exosome-Based Therapeutic Development Summit - pharmaphorum

pharmaphorum - Jul 02, 2025

Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats - Nature

Nature - Oct 22, 2020

Six exosome therapy companies driving development in the field - Labiotech.eu

Labiotech.eu - Nov 14, 2024

Funding Flows Freely into Exosome Therapeutics in 2025 - bioinformant.com

bioinformant.com - Jan 04, 2025

Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - PR Newswire

PR Newswire - Nov 04, 2024

Exosomes as a Burgeoning New Frontier in Cell-Free Therapeutics - bioinformant.com

bioinformant.com - Jun 11, 2024

Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight - PR Newswire

PR Newswire - Mar 17, 2026

Designer Exosomes: The Future of Targeted Therapy and Regenerative Medicine - bioinformant.com

bioinformant.com - Apr 09, 2025

The Emerging Role of Exosome Therapeutics in 2026 - bioinformant.com

bioinformant.com - Dec 29, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment